These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 20708938)
1. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Sellers RP; Alexander LD; Johnson VA; Lin CC; Savage J; Corral R; Moss J; Slugocki TS; Singh EK; Davis MR; Ravula S; Spicer JE; Oelrich JL; Thornquist A; Pan CM; McAlpine SR Bioorg Med Chem; 2010 Sep; 18(18):6822-56. PubMed ID: 20708938 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action. Alexander LD; Sellers RP; Davis MR; Ardi VC; Johnson VA; Vasko RC; McAlpine SR J Med Chem; 2009 Dec; 52(24):7927-30. PubMed ID: 20014866 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90. Kunicki JB; Petersen MN; Alexander LD; Ardi VC; McConnell JR; McAlpine SR Bioorg Med Chem Lett; 2011 Aug; 21(16):4716-9. PubMed ID: 21764310 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines. Pan PS; Vasko RC; Lapera SA; Johnson VA; Sellers RP; Lin CC; Pan CM; Davis MR; Ardi VC; McAlpine SR Bioorg Med Chem; 2009 Aug; 17(16):5806-25. PubMed ID: 19643615 [TBL] [Abstract][Full Text] [Related]
5. Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity. Zapf CW; Bloom JD; McBean JL; Dushin RG; Nittoli T; Ingalls C; Sutherland AG; Sonye JP; Eid CN; Golas J; Liu H; Boschelli F; Hu Y; Vogan E; Levin JI Bioorg Med Chem Lett; 2011 Apr; 21(8):2278-82. PubMed ID: 21420297 [TBL] [Abstract][Full Text] [Related]
6. Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins. Ardi VC; Alexander LD; Johnson VA; McAlpine SR ACS Chem Biol; 2011 Dec; 6(12):1357-66. PubMed ID: 21950602 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines. Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604 [TBL] [Abstract][Full Text] [Related]
8. C-terminal heat shock protein 90 modulators produce desirable oncogenic properties. Wang Y; McAlpine SR Org Biomol Chem; 2015 Apr; 13(16):4627-31. PubMed ID: 25711919 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold. Jia JM; Liu F; Xu XL; Guo XK; Jiang F; Cherfaoui B; Sun HP; You QD Bioorg Med Chem Lett; 2014 Mar; 24(6):1557-61. PubMed ID: 24582477 [TBL] [Abstract][Full Text] [Related]
10. Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. Casale E; Amboldi N; Brasca MG; Caronni D; Colombo N; Dalvit C; Felder ER; Fogliatto G; Galvani A; Isacchi A; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Casuscelli F Bioorg Med Chem; 2014 Aug; 22(15):4135-50. PubMed ID: 24980703 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of novel sansalvamide A derivatives. Carroll CL; Johnston JV; Kekec A; Brown JD; Parry E; Cajica J; Medina I; Cook KM; Corral R; Pan PS; McAlpine SR Org Lett; 2005 Aug; 7(16):3481-4. PubMed ID: 16048322 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Evaluation of Heat Shock Protein 90 Inhibitors in Human Breast Cancer and Its Metastasis. Gümus M; Ozgur A; Tutar L; Disli A; Koca I; Tutar Y Curr Pharm Biotechnol; 2016; 17(14):1231-1245. PubMed ID: 27804852 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors. Gunaherath GM; Marron MT; Wijeratne EM; Whitesell L; Gunatilaka AA Bioorg Med Chem; 2013 Sep; 21(17):5118-29. PubMed ID: 23859777 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. Shao LD; Su J; Ye B; Liu JX; Zuo ZL; Li Y; Wang YY; Xia C; Zhao QS J Med Chem; 2017 Nov; 60(21):9053-9066. PubMed ID: 29019670 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis. Koca İ; Özgür A; Er M; Gümüş M; Açikalin Coşkun K; Tutar Y Eur J Med Chem; 2016 Oct; 122():280-290. PubMed ID: 27376491 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. Malayeri SO; Abnous K; Arab A; Akaberi M; Mehri S; Zarghi A; Ghodsi R Bioorg Med Chem; 2017 Feb; 25(3):1294-1302. PubMed ID: 28073608 [TBL] [Abstract][Full Text] [Related]